TheStreet’s Jim Cramer answers viewer questions from social media on the floor of the New York Stock Exchange. There was plenty of talk about Ambarella (AMBA), the HD video processing company dropped 40 percent since summer. ‘Ambarella is very linked to GoPro (GPRO),’ he said. ‘There’s a survey out by Piper Jaffray saying that teens don’t like using GoPro, which means Ambarella takes another hit.’ With Ferrari gearing up to go public, investors are eyeing the stock. ‘Ferrari is going to be an interesting opportunity because everyone’s going to like a stock by the name of RACE,’ said Cramer. With the holidays coming up, travel stocks are coming into focus. Trip Advisor (TRIP) is making headlines after forging a room booking deal with Priceline (PCLN). Customers will now be able to book hotel rooms directly through the travel review website. Cramer is pro the idea. ‘Trip Advisor and Priceline deserve to be one company, that’s how seamless this will make them,’ he said. ‘I like Expedia (EXPE) too.’ Other questions from viewers touched on the pharmaceutical industry. Rumors have been circulating that Pfizer (PFE) may buyout Allergan (AGN) once the company’s deal with Teva Pharmaceuticals (TEVA) has been completed.
More from Video
Amid the Selling, Here's the Big Question Now
How quickly do we find support, is what we'll want to know now, as the correction is occurring while economic optimism builds.
One Tweet Pulls the Rug Out From Under the Indexes
Despite the president's promise of no stimulus until after Nov. 3, there are no signs yet that this is the sort of correlated selling that leads to a deep correction.
A Technical Look at the New Dow Jones Industrial Average
Salesforce, Amgen and Honeywell will give a lift to the DJIA going forward.
Conagra Brands Looks Tastier After Its Upgrade to Buy
CAG has hung onto the bulk of its recent gains, and could rise to the $50 area, according to the charts and indicators.
Biogen Bulls Get a Lift From Quant Upgrade and Strengthening Charts
Breaking down an approach to the long side of this biotech stock.
Real Money's message boards are strictly for the open exchange of investment ideas among registered users. Any discussions or subjects off that topic or that do not promote this goal will be removed at the discretion of the site's moderators. Abusive, insensitive or threatening comments will not be tolerated and will be deleted. Thank you for your cooperation.
If you have questions, please contact us here.